# Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain

> **NCT00941746** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 56 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** PG110
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00941746
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941746, "Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00941746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*